logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

WCLC 2019 – A non-invasive complementary biomarker improves the efficacy of lung cancer screening

Results of bioMILD trial indicate that longer LDCT screening intervals are feasible and safe in selected high-risk subjects